196 related articles for article (PubMed ID: 17397254)
21. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
[TBL] [Abstract][Full Text] [Related]
22. Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies.
Delobel P; Nugeyre MT; Cazabat M; Pasquier C; Marchou B; Massip P; Barre-Sinoussi F; Israël N; Izopet J
J Clin Microbiol; 2007 May; 45(5):1572-80. PubMed ID: 17329448
[TBL] [Abstract][Full Text] [Related]
23. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
[TBL] [Abstract][Full Text] [Related]
24. CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals.
Low AJ; Marchant D; Brumme CJ; Brumme ZL; Dong W; Sing T; Hogg RS; Montaner JS; Gill V; Cheung PK; Harrigan PR
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):219-28. PubMed ID: 18240966
[TBL] [Abstract][Full Text] [Related]
25. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.
Ogert RA; Lee MK; Ross W; Buckler-White A; Martin MA; Cho MW
J Virol; 2001 Jul; 75(13):5998-6006. PubMed ID: 11390601
[TBL] [Abstract][Full Text] [Related]
26. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
[TBL] [Abstract][Full Text] [Related]
27. Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
Schwalbe B; Schreiber M
PLoS One; 2015; 10(3):e0119879. PubMed ID: 25785610
[TBL] [Abstract][Full Text] [Related]
28. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
[TBL] [Abstract][Full Text] [Related]
29. Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model.
Skrabal K; Low AJ; Dong W; Sing T; Cheung PK; Mammano F; Harrigan PR
J Clin Microbiol; 2007 Feb; 45(2):279-84. PubMed ID: 17122004
[TBL] [Abstract][Full Text] [Related]
30. Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5.
Da LT; Wu YD
J Chem Inf Model; 2011 Feb; 51(2):359-69. PubMed ID: 21284403
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.
Moncunill G; Armand-Ugón M; Pauls E; Clotet B; Esté JA
AIDS; 2008 Jan; 22(1):23-31. PubMed ID: 18090388
[TBL] [Abstract][Full Text] [Related]
32. Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants.
Edo-Matas D; van Dort KA; Setiawan LC; Schuitemaker H; Kootstra NA
Virology; 2011 Apr; 412(2):269-77. PubMed ID: 21295814
[TBL] [Abstract][Full Text] [Related]
33. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
Labrosse B; Treboute C; Brelot A; Alizon M
J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
[TBL] [Abstract][Full Text] [Related]
34. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
Meister S; Otto C; Papkalla A; Krumbiegel M; Pöhlmann S; Kirchhoff F
Virology; 2001 Jun; 284(2):287-96. PubMed ID: 11384227
[TBL] [Abstract][Full Text] [Related]
35. An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.
Bozek K; Eckhardt M; Sierra S; Anders M; Kaiser R; Kräusslich HG; Müller B; Lengauer T
Retrovirology; 2012 Jul; 9():60. PubMed ID: 22830600
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 gp120-CXCR4 recognition probed with synthetic nanomolar affinity D-peptides containing fragments of gp120 V3 loop.
Zhu R; Meng Q; Zhang H; Zhang G; Huang LSM; Xu Y; Schooley RT; An J; Huang Z
Eur J Med Chem; 2022 Dec; 244():114797. PubMed ID: 36270088
[TBL] [Abstract][Full Text] [Related]
37. Highly Accurate Structure-Based Prediction of HIV-1 Coreceptor Usage Suggests Intermolecular Interactions Driving Tropism.
Kieslich CA; Tamamis P; Guzman YA; Onel M; Floudas CA
PLoS One; 2016; 11(2):e0148974. PubMed ID: 26859389
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 CRF01_AE coreceptor usage prediction using kernel methods based logistic model trees.
Shoombuatong W; Hongjaisee S; Barin F; Chaijaruwanich J; Samleerat T
Comput Biol Med; 2012 Sep; 42(9):885-9. PubMed ID: 22824642
[TBL] [Abstract][Full Text] [Related]
39. A predictive model for HIV type 1 coreceptor selectivity.
Kieslich CA; Shin D; López de Victoria A; González-Rivera G; Morikis D
AIDS Res Hum Retroviruses; 2013 Oct; 29(10):1386-94. PubMed ID: 23808984
[TBL] [Abstract][Full Text] [Related]
40. Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120.
Chandramouli B; Chillemi G; Giombini E; Capobianchi MR; Rozera G; Desideri A
J Biomol Struct Dyn; 2013 Apr; 31(4):403-13. PubMed ID: 22876913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
